{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:50:22Z","timestamp":1782201022947,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002560","name":"Soonchunhyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00217123"],"award-info":[{"award-number":["RS-2023-00217123"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["2021R1G1A1093208"],"award-info":[{"award-number":["2021R1G1A1093208"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cgh.2025.09.039","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:08:22Z","timestamp":1761185302000},"page":"1897-1905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-8180","authenticated-orcid":false,"given":"Hye Yeon","family":"Chon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Joon","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Jae","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lai-Hung Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Che-To Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Cheuk-Fung Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyune","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Seok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-4503","authenticated-orcid":false,"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2025.09.039_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3350\/cmh.2022.0342","article-title":"Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection","volume":"29","author":"Lin","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"Suppl","key":"10.1016\/j.cgh.2025.09.039_bib2","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.3350\/cmh.2024.0163","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: systematic review and meta-analysis","volume":"30","author":"Jin","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib3","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.3748\/wjg.v22.i29.6663","article-title":"Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection","volume":"22","author":"Zeng","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2025.09.039_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1016\/j.cgh.2025.09.039_bib5","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2024.0506","article-title":"Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease","volume":"30","author":"Kim","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib6","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.cgh.2023.03.005","article-title":"aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in chronic hepatitis B patients","volume":"21","author":"Fan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/MEG.0000000000001794","article-title":"Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B","volume":"33","author":"Chon","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib8","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3390\/diagnostics12112646","article-title":"Dynamic changes in liver stiffness in patients with chronic hepatitis B undergoing antiviral therapy","volume":"12","author":"Lazar","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cgh.2025.09.039_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1751-2980.13172","article-title":"CAGE-B and SAGE-B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE-B","volume":"24","author":"Chon","year":"2023","journal-title":"J Dig Dis"},{"key":"10.1016\/j.cgh.2025.09.039_bib10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3350\/cmh.2022.0084","article-title":"KASL clinical practice guidelines for management of chronic hepatitis B","volume":"28","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/kjhep.2012.18.1.1","article-title":"Korean Association for the Study of the Liver. Revision and update on clinical practice guideline for liver cirrhosis","volume":"18","author":"Suk","year":"2012","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3350\/cmh.2022.0294","article-title":"2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma","volume":"28","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2008.01802.x","article-title":"Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B","volume":"29","author":"Marcellin","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2025.09.039_bib14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","article-title":"Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","volume":"69","author":"Kim","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.cgh.2018.11.001","article-title":"Efficacy and safety of besifovir dipivoxil maleate compared with tenofovir disoproxil fumarate in treatment of chronic hepatitis B virus infection","volume":"17","author":"Ahn","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3350\/cmh.2019.1002","article-title":"KASL clinical practice guidelines for management of chronic hepatitis B","volume":"25","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib19","article-title":"External validation of aMAP hepatocellular carcinoma risk score in patients with chronic hepatitis B-related cirrhosis receiving ETV or TDF therapy","volume":"8","author":"Gui","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cgh.2025.09.039_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28210","article-title":"Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B","volume":"95","author":"Kaneko","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.cgh.2025.09.039_bib21","article-title":"Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection","volume":"3","author":"Innes","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2025.09.039_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5009\/gnl220386","article-title":"Prediction of hepatocellular carcinoma development in Korean patients after hepatitis C cure with direct-acting antivirals","volume":"18","author":"Hong","year":"2023","journal-title":"Gut Liver"},{"key":"10.1016\/j.cgh.2025.09.039_bib23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2025.09.039_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12876-023-02846-9","article-title":"Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study","volume":"23","author":"Cho","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2025.09.039_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3350\/cmh.2021.0179","article-title":"Entecavir versus tenofovir in patients with chronic hepatitis B: enemies or partners in the prevention of hepatocellular carcinoma","volume":"27","author":"Lee","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5009\/gnl220390","article-title":"Noninferiority outcomes of besifovir compared to tenofovir alafenamide in treatment-na\u00efve patients with chronic hepatitis B","volume":"18","author":"Kim","year":"2024","journal-title":"Gut Liver"},{"key":"10.1016\/j.cgh.2025.09.039_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3350\/kjhep.2009.15.2.140","article-title":"[Distribution of hepatitis B virus genotypes in Korea]","volume":"15","author":"Cho","year":"2009","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.cgh.2025.09.039_bib29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fphar.2018.01290","article-title":"A systematic review of medication adherence thresholds dependent of clinical outcomes","volume":"9","author":"Baumgartner","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cgh.2025.09.039_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12876-020-01219-w","article-title":"Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes","volume":"20","author":"Allard","year":"2020","journal-title":"BMC Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525008663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525008663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:36:04Z","timestamp":1782200164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525008663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1542356525008663"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2025.09.039","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-Male-Albumin-Bilirubin-Platelet (aMAP) and Liver Stiffness Assessed by Vibration-Controlled Transient Elastography","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2025.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Gastroenterological Association Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}